Isoray Inc. is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding brachytherapy treatments for difficult to treat cancers.
Isoray Inc. Designs and Develops Brachytherapy Products: Isoray is an innovative company that designs and develops state-of-the-art, personalized brachytherapy products that provide a more cost-effective cancer treatment. Isoray employs approximately 40 employees, dedicated to the introduction of a unique isotope for the treatment of both common and also difficult to treat cancers. Isoray Inc. Is the Sole Producer of Cesium-131 Brachytherapy Sources: Cesium 131 has unique characteristics that have evolved into an effective treatment for many types of cancer. Specifically, Cesium 131 is able to provide a highly targeted, fast-acting radiation treatment that is able to deliver its energy in a shorter time period than conventional external beam radiation therapy or other isotopes currently used in brachytherapy, which is not only more cost-effective but typically results in less treatment side-effects.
Cesium-131 brachytherapy sources are expanding brachytherapy treatments for difficult to treat cancers. Isoray is dedicated to pioneering cost-effective solutions for life beyond a patient’s cancer.
Isoray Inc. Was Founded in 1983: The company was founded by Lance A. Bray and is headquartered in Richland, WA.
Industry: Health > Health Conditions > Cancer
More information about Isoray
|Address||StreetAddress: 350 Hills St Ste 106, AddressLocality: Richland, AddressRegion: Washington, PostalCode: 99354, AddressCountry: United States|
|Number Of Employees||61|
|Ticker Symbol||NYSEMKT: ISR|
New York City, US
20 Sep 2023
Isoray Inc. is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding brachytherapy treatments for difficult to treat cancers. Isoray is a registered manufacturer with the FDA and holds multiple 510 clearances for brachytherapy devices.en.wikipedia.org/wiki/IsoRay
Stock price : CATX (NYSEAMERICAN) $0.29 -0.03 (-10.72%)Sep 19, 4:00 PM EDT - Disclaimer
Headquarters : Seattle, WA
Founded : 2004
Subsidiaries : Viewpoint Molecular Targeting, Inc., Isoray Medical, IsoRay International LLC, Select
|Entity Home||Kalicube Pro Entity Page|